Rejecting Arsenate

English

 

Not long ago, some unassuming bacteria found themselves at the center of a scientific controversy: A group claimed that these microorganisms, which live in an environment that is rich in the arsenic-based compound arsenate, could take up that arsenate and use it – instead of the phosphate on which all known life on Earth depends. The claim, since disproved, raised another question: How do organisms living with arsenate pick and choose the right substance?


Chemically, arsenate is nearly indistinguishable from phosphate. Prof. Dan Tawfik of the Biological Chemistry Department says: “Phosphate forms highly stable bonds in DNA and other key biological compounds, while bonds to arsenate are quickly broken. But how does a microorganism surrounded by arsenate distinguish between two molecules that are almost the same size and have identical shapes and ionic properties?”
 
To investigate, Tawfik, postdoctoral fellow Dr. Mikael Elias, Ph.D. student Alon Wellner and lab assistant Korina Goldin, in collaboration with Tobias Erb and Julia Vorholt of ETH Zurich, looked at a protein in bacteria that takes up phosphate. This protein, called PBP (short for phosphate binding protein), sits near the bacteria’s outer membrane, where it latches onto phosphates and passes them on to pumps that transport them into the cell.

In research that recently appeared in Nature, the team compared the activity of several different PBPs – some from bacteria like E. coli that are sensitive to arsenate and others, like those from the arsenic-rich environment, which are tolerant of the chemical. While the PBPs in the ordinary bacterium were about 500 times more likely to bind phosphate over arsenate, in the arsenic-tolerant bacterium that factor jumped to around 5000. In other words, to cope with their toxic environment, the bacteria evolved a mechanism of extreme selectivity to ensure their supply of phosphate while keeping the arsenate out.

Elias then compared phosphate and arsenate binding by crystallizing PBPs along with one of the two compounds. But the initial comparison suggested that when arsenate bound to the protein, it did so in just the same way as phosphate. Elias suspected that the key might lie in a single, highly unusual bond between a hydrogen atom in the protein and the molecule. This bond had been previously noted but ignored, as phosphate binding occurred with or without it.

To see the difference, the team had to stretch the limits of crystallization technology, getting the resolution to less than one angstrom – fine enough to identify individual hydrogen atoms and compare their bonds. Only then were they able to identify a single disparity: The angles of that unusual hydrogen bond were different. Inside a tight cavity within the PBP structure, phosphate binds at a “textbook angle,” according to Elias. The slightly larger arsenate molecule, on the other hand, gets pushed up against the hydrogen and bonds at unnatural, distorted angles. Tawfik thinks that the angle is likely to lead to repulsion between the molecule and other atoms in the cavity, preventing the PBP from passing arsenate into the cell’s interior.

Tawfik: “These findings may go beyond the solving of a biological mystery. Because phosphates are scarce in many environments, there is quite a bit of interest in understanding how this crucial resource is taken up by organisms. This first observation of a PBP discrimination mechanism is an exciting demonstration of the exquisite fine tuning that enables proteins to distinguish between two nearly-identical molecules.”
 
Prof. Dan Tawfik’s research is supported by the Adelis Foundation; the estate of Mark Scher; and Ms. Miel de Botton, UK. Prof. Tawfik is the incumbent of the Nella and Leon Benoziyo Professorial Chair.

 
Life Sciences
English

Rescuing the Rescuers

English

(l-r) Dr. Gili Ben-Nissan, Prof. Yosef Shaul, Dr. Michal Sharon and Oren Moscovitz

 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
One of the ways our cells keep things running smoothly is by recycling all sorts of proteins, especially those that are damaged or have outlived their usefulness. But how does the cell avoid consigning to the recycling bin those proteins that are still serving important functions? New research led by Dr. Michal Sharon of the Biological Chemistry Department reveals how one enzyme works to rescue vital proteins from unwanted demolition. Among other things, this enzyme saves from the cell’s protein recycler two proteins that help stop cancerous growth – p53 and p73 – and thus may play a role in protecting against cancer.

Dismantling proteins can be a “bureaucratic” process in which those slated for demolition are first labeled with special tags called ubiquitin and then sent off to the “Department of Protein Disassembly,” otherwise known as the proteasome. In the proteasome, the tags are read in one unit and then the protein is ushered into the next unit, where it is broken down for parts. The discovery of this bureaucratic process earned Rose, Hershko and Ciechanover a Nobel Prize in 2004. In recent years, however, researchers have come to realize that a parallel, more passive, dismantling process can occur in the same machinery. This process targets proteins that are unfolded – either along part of their lengths or completely. Such proteins can find themselves swept into the demolition unit without having first gone through the tagging and checking stage. Almost a third of the cell’s proteins contain unfolded segments and a fifth eventually undergo this type of disassembly, yet many of them play crucial roles in regulation and signaling. With no tagging system to sort them out, how does the cell protect the needed proteins from the degradation machinery?

Investigating this question was complicated, as the two pathways – the bureaucratic and the passive – exist side by side in the same machinery.

Several years ago, Prof. Yosef Shaul, Head of the Molecular Genetics Department, revealed a part of the answer: He identified the “rescuer” that prevents unwanted dismantling. This rescuer, an enzyme called NQO1, is an all-around protector of the cell: In addition to keeping vital proteins from being broken down, it was known to fight against reactive oxygen compounds, thus protecting the cell from oxidative damage.
 
 
Mutual deterrence: The proteasome breaks down NQO1 enzymes that lack structure (unbound to FAD), while binding to FAD prevents protein destruction by the proteasome – including that of the enzyme, itself
 
To investigate how NQO1 saves proteins from dismantling, Oren Moscovitz, Nimrod Hazan, Hodaya Keisar, and Drs. Gili Ben-Nissan and Izhak Michaelevsky in Sharon’s group created a simplified version of the recycling process. Into their experimental system went enzymes and the recycling unit of the proteasome. By leaving out the first proteasome unit – the one that checks the ubiquitin tags – they were assured of observing just the passive dismantling pathway. Next, the researchers added another molecule – one derived from vitamin B2 called FAD. The binding of FAD molecules to NQO1 is necessary for it to carry out its cellular duties.

Observing the NQO1 enzyme using the advanced mass spectrometry equipment in Sharon’s lab, the team discovered that the bound FAD molecules serve to stabilize the enzyme’s structure. They then tested this observation with a mutant NQO1 enzyme in which the FAD binding site is defective, as well as checking what happened when they removed FAD from a normal molecule. In both cases, the result was a shapeless, unfolded enzyme that disappeared from the experimental system, as it was dismantled in the proteasome grinder unit. When they added large quantities of FAD to the system, the enzymes – both normal and mutant – resumed their organized shapes and were saved from demolition.

Together with Shaul and his research student Peter Tsvetkov, the team tested their findings in living cells. They found that giving vitamin B2 to these cells not only increased NQO1 levels and stabilized its structure, it also boosted p53 levels. Further testing on breast cancer cells in which FAD binding was faulty added to the picture: Giving these cells B2 rescued the NQO1 that would have been dismantled, and it, in turn, saved the cells’ p53. Since p53 is so important for preventing cancer, says Moscovitz, “we think of this as ‘to B2 or not to be.’”

The findings, which appeared recently in Molecular Cell, show that the relationship between the proteasome and NQO1 is based on a sort of mutual deterrence. The proteasome does, indeed, dismantle NQO1 enzymes that lack a complete structure, while enzymes with stable structures can block the actions of the proteasome, rescuing other proteins in the process. The factor that tips the scales is vitamin B2, a nutrient that is absorbed from outside the body. The scientists think that the phenomenon they have discovered – a metabolic factor that directs the functioning of a system by affecting the shape of one of its components – may be found in other cellular pathways, as well.

The mutation that obstructs NQO1 binding to FAD is found in around 4% of the human population and a fifth of all Asians. The cells of people with this mutation do not cope well with oxidative stress, and they contain particularly low levels of p53 and p73. These people tend to be susceptible to cancer – especially breast cancer and leukemia. Thus the findings, which suggest that large quantities of vitamin B2 might overcome this problem, hint at a possible new and important role for this nutrient.
 
Dr. Michal Sharon’s research is supported by the Wolfson Family Charitable Trust; and Karen Siem, UK. Dr. Sharon is the incumbent of the Elaine Blond Career Development Chair in Perpetuity.

Prof. Yosef Shaul’s research is supported by the M.D. Moross Institute for Cancer Research; the Leo and Julia Forchheimer Center for Molecular Genetics, which he heads; the Leona M. and Harry B. Helmsley Charitable Trust; the Ben May Charitable Trust; and the Cure Foundation. Prof. Shaul is the incumbent of the Oscar and Emma Getz Professorial Chair.
 
 

 

 

(l-r) Dr. Gili Ben-Nissan, Prof. Yosef Shaul, Dr. Michal Sharon and Oren Moscovitz
Life Sciences
English

Yeast Side Story

English
 
Yeast cells yearning for a “soul mate” have a problem: They lack the ability to move on their own. To get closer to a potential mate, all they can do is reach out with cellular extensions. This enables a pair of yeast cells to make contact, after which they fuse their membranes together and ultimately merge their genomes.
Cell Reports cover: Illustration by Dr. Rita Gelin-Licht showing yeast cells mating through extensions
 
Prof. Jeffrey Gerst of the Weizmann Institute’s Molecular Genetics Department has now discovered the mechanism that controls the growth of yeast cell extensions called shmoos in a particular direction, making sure the cells can engage in successful mating. This same control mechanism is predicted to govern the growth of cellular extensions in organisms other than yeast – for example, the growth of neurons towards attractive signals or away from repellent signals in the human brain.
 
The scientists found that when yeast cells ready for sexual reproduction receive a chemical signal from a prospective “mate,” they respond by sending specific messenger RNA (mRNA) molecules – whose job is to convey DNA-encoded information to be translated into proteins – to the point on their membrane where the mating signal has been received. This prompts the cells to start growing shmoos in the direction of the mate, a process called chemotropism. They also revealed how mRNA reaches this location: They identified a protein, called Scp160, that is activated by the mating signal and guides the needed mRNAs to the appropriate spot near the cell surface. When the scientists created a mutation in Scp160, disrupting its activity, yeast cells grew extensions in the wrong direction and failed to mate. Taking part in the study, published recently in Cell Reports, was Rita Gelin-Licht, then Gerst’s graduate student, as well as Saurabh Paliwal, Patrick Conlon and Andre Levchenko of Johns Hopkins University.
 
 
In earlier research, Gerst had already shown that mRNA movements around the cell are not random; rather, its protein-making information is targeted to the exact spot or spots where this protein will eventually be needed. In the present study, Gerst and his team showed for the first time that mRNA targeting is crucial for the cell to respond properly to external chemotropic signals.
Prof. Jeffrey Gerst
 
If these findings are found to be applicable to neurons, they might shed new light on the wiring of the human brain. They may help explain how the brain neurons grow the lengthy projections that link up into precise neural networks that transmit electric signals throughout the brain.
 
Prof. Jeffrey Gerst's research is supported by the Miles and Kelly Nadal and Family Laboratory for Research in Molecular Genetics; the Hugo and Valerie Ramniceanu Foundation; the Y. Leon Benoziyo Institute for Molecular Medicine; the Yeda-Sela Center for Basic Research; and the estate of Raymond Lapon. Prof. Gerst is the incumbent of the Besen-Brender Professorial Chair of Microbiology and Parasitology.
 
 
 
Cell Reports cover: Illustration by Dr. Rita Gelin-Licht showing yeast cells mating through extensions
Life Sciences
English

Taking Stock of Calcium

English

 


(l-r) Ido Kaminsky, Prof. Eitan Reuveny, Ruth Meller, Raz Palty and Dr. Adi Raveh. Steady supply

 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Calcium is one of the most regulated minerals in the human body. That may be because so many important cellular processes rely on calcium ions: cell growth, neural signaling, muscle contraction, bone formation and fertilization, to name just a few. In fact, it is crucial that a low yet steady concentration of calcium ions be maintained within cells: There is growing evidence that disturbances in intracellular calcium levels may result in serious cellular dysfunction. For example, an excessive amount of calcium in nerve cells causes them to die, leading to neurodegenerative disease. Imbalances in calcium levels are also believed to be associated with various types of cancer as well as vascular and heart diseases.
 
Cells have evolved a unique “stocktaking” system to ensure their calcium supplies are tightly monitored and regulated. Prof. Eitan Reuveny of the Weizmann Institute’s Biological Chemistry Department has now discovered the role of a new protein that is involved in this process.

To make sure there is a plentiful supply of calcium on hand at all times – one that doesn’t jeopardize the carefully balanced concentration within the cell – calcium is stored in cellular “warehouses”: membrane-enclosed organelles known as mitochondria and the endoplasmic reticulum (ER). These immediately get restocked as soon as their supplies start to dwindle. How does the cell know exactly how much calcium to order? The process of acquiring more calcium is called store-operated calcium entry (SOCE), and up to now two players were known to be involved – STIM and Orai. STIM – a “stock-taker” protein – detects the depletion of calcium within the ER warehouses and makes its way to Orai – calcium-selective channels located in the cell’s plasma membrane – where it activates them to open. This results in an influx of calcium into the cell from the outside, which then gets taken up by the cellular warehouses.

 
SARAF1Fluorescent images of a HEK293-T cell expressing SARAF-GFP (green) and STIM1-mCherry (red). Third panel is an overlay
 

 

What scientists didn't know was what regulates the closing of these channels, preventing the cellular warehouses from overfilling and spilling out into the cell. Now, Reuveny, together with Raz Palty, Adi Raveh, Ido Kaminsky and Ruth Meller, have identified a new protein that helps regulate SOCE activity, as they reported in the journal Cell. They found that once the Orai channels have opened, the new protein, SARAF, is employed to slowly inactivate STIM, causing the channels to start closing. This prevents the rapid overfilling of cells with calcium and keeps levels under control.

As expected, disabling SARAF activity led to calcium overspill and cell hyperactivity. The added observation that SARAF travels with STIM to the plasma membrane, where the Orai channels are located, provides further evidence that SARAF is involved in regulating STIM deactivation.

Although there is no direct evidence linking mutations in SARAF to human diseases, studies have recently identified SARAF as a biomarker that is associated with prostate cancer, Alzheimer’s disease and dilated cardiomyopathy – disease states that are accompanied by abnormal intracellular calcium levels.

Reuveny: “SARAF is expressed in cells all over the body, but their levels are especially high in the immune system and brain. We still don’t know exactly what it does there or how it works, so this is what we are endeavoring to find out next.”
 
SARAF tagged with green fluorescent protein. The fluorescent signals get stronger as SARAF moves closer to the plasma membrane.
 
 
Prof. Eitan Reuveny’s research is supported by the Nella and Leon Benoziyo Center for Neurological Diseases; the Yeda-Sela Center for Basic Research; and the Hugo and Valerie Ramniceanu Foundation. Prof. Reuveny is the incumbent of the Charles H. Hollenberg Professorial Chair. 

 
 
 

 

 

 

 
(l-r) Ido Kaminsky, Prof. Eitan Reuveny, Ruth Meller, Raz Palty and Dr. Adi Raveh. Steady supply
Space & Physics
English

Matchmaker

English
Dr. Sarel Fleishman. Designed to fit
 
Does the perfect match exist? Despite the promises of numerous dating sites, finding the ideal mate is rarely a rational, systematic process. Until now, the same could be said for matches between protein molecules. We might be able to observe which proteins get together – which pairings initiate molecular processes and which block them – but we haven’t really been able to generate novel, “perfect” matches from scratch.

This situation is now changing, however, thanks to a new method, the first of its kind, for “fine tuning”  various physical features on the surface of a protein molecule. The method, developed by Dr. Sarel Fleishman – who recently joined the Institute’s Biological Chemistry Department – and his colleagues at the University of Washington, Seattle, enables researchers to redesign the surface of protein molecules so that they will match up with target proteins and strongly bind to them.
 
For instance, the scientists created new proteins that can bind to the active site on the surface of a flu virus, obstructing its activities. This particular site has been conserved throughout the evolution of the flu, so it is found in many strains including bird and swine flu. Thus a protein molecule like the one Sarel and his colleagues programmed to target that site could conceivably block a range of flu viruses. The therapeutic potential of these molecules is currently being investigated.

In addition to sophisticated computer analyses of the physical properties of protein molecules, the system makes use of a number of online databases of protein molecule structures (including pioneering databases developed at the Weizmann Institute). According to Fleishman, the process begins with a theoretical computation to determine the ideal molecular structure needed to perfectly bind to the active site of a target protein. The next step is to scan the protein structure databases to find natural molecules into which the programmed active site might feasibly be integrated.
 
 
In the case of the new flu-binding protein, several dozen proteins were altered to include the new binding site. Of these, five succeeded in the lab in binding to the targets. One of the five managed to block the ability of various flu viruses to spread.
 
The molecular structure of Spanish flu protein (hemagglutin) bound to a computationally designed protein (green). The designed protein binds the viral protein tightly and with high specificity, blocking the protein's function and neutralizing viral infectivity
 
“Basically,” says Fleishman, “by combining our computational tools with an experimental approach, we were able to create molecules that don’t exist in nature. Such programmed molecules could give us the ability to direct molecular activities, and they might have a wide range of uses in medicine, diagnostic tools and biotechnology.” In other words, nearly ideal matches – ones that don’t exist in nature – can now be produced with a computer and a biology lab. The method might be used, in the future, to design a variety of new drugs, including those to combat emerging diseases for which current drugs may be ineffective.
 
Dr. Sarel-Jacob Fleishman’s research is supported by Sam Switzer and family; the Geffen Trust; and the Yeda-Sela Center for Basic Research.

 
 
The molecular structure of Spanish flu protein (hemagglutin) bound to a computationally designed protein (green). The designed protein binds the viral protein tightly and with high specificity, blocking the protein's function and neutralizing viral infectivity
Life Sciences
English

At the Core

English
 
ISPC illustration
"Structural Biology is a scientific area in which Israeli scientists have been leading for many years, as evidenced by the Weizmann Institute's Prof. Ada Yonath, who won a Nobel Prize in 2009 for her pioneering work on solving the structure of ribosomes," says the Institute's Prof. Joel Sussman, Director of Israel’s Instruct Core Centre.

This Centre, which is operated jointly with Tel Aviv University, is one of seven Core Centres recently founded in prestigious institutions, mainly in Europe. They are a part of Instruct (Integrated Structural Biology Infrastructure), which aims to give pan-European users access to state-of-the-art equipment, technologies and manpower in cellular structural biology. This will enable Europe to maintain a competitive edge and play a leading role in this vital research area.

Central to the decision to locate the Instruct Core Centre in Israel is the Israel Structural Proteomics Center (ISPC) established by scientists from the Weizmann Institute, with Sussman as its director, to increase the efficiency of protein structure determination.

The founding agreement, signed in February at a ceremony in Brussels, will mean that "Israeli scientists and their European counterparts will now have access to facilities they could only have dreamed of before," says the Weizmann Institute’s Prof. Gideon Schreiber, Deputy Director of Israel's Instruct Core Centre as well as of the ISPC. "We hope this core centre will stimulate new collaborative research projects between laboratories throughout Europe with the Weizmann Institute as well as with other Israeli institutions, and also attract more graduate students, postdoctoral fellows and visiting scientists from all over the world."
 
Prof. Joel Sussman's research is supported by Mr. and Mrs. Yossie Hollander, Israel; the Jean and Jula Goldwurm Memorial Foundation; the Samuel Aba and Sisel Klurman Foundation; the Bruce H. and Rosalie N. Rosen Family Foundation; Mr. and Mrs. Howard Garoon, Glencoe, IL; and the Nalvyco Trust. Prof. Joel Sussman is the incumbent of the Morton and Gladys Pickman Professorial Chair in Structural Biology.
 

 

 
 Israel Structural Proteomics Center (ISPC) illustration
Chemistry
English

Defending Against Chemical Acts of Terrorism

English

 

 

 

 
Researchers may have found a way to protect us against otherwise deadly chemical attacks, such as the subway sarin incident in Tokyo that left thirteen people dead and thousands more injured or with temporary vision problems. The method is based on a new and improved version of a detoxifying enzyme produced naturally by our livers, according to the report in the April 2012 issue of Chemistry & Biology, a Cell Press publication.

"The sarin attack in Tokyo in 1995 demonstrated that both the raw materials and know-how of producing deadly nerve agents are available to people outside government or military institutions," said Moshe Goldsmith of the Weizmann Institute of Science in Israel. "We hope that our work would provide a prophylactic drug that will effectively protect the medical, police, and other teams that will have to act in a contaminated area following such an attack and would also provide these teams with a drug that could be administered on-site to intoxicated individuals to greatly improve their chances of survival."

Today, protection against nerve agents relies primarily on physical barriers such as gas masks and protective suits that can easily be breached, Goldsmith explained. Following exposure, people are treated with drugs that help with the symptoms but don't eliminate the nerve agent.

Goldsmith and the study's senior author Dan Tawfik hope to change this, relying on the principles of evolution to produce a more efficient version of an enzyme that occurs naturally in all of us. Known as paraoxonase 1 (PON1), this enzyme was originally named for its ability to assist in the breakdown of the insecticide paraoxon. It is also involved in drug metabolism and detoxification.

PON1 normally does counteract G-type nerve agents, including sarin, tabun, soman, and cyclosarin, but not well enough. Tawfik's lab specializes in a technique called "directed enzyme evolution, "in which they artificially introduce mutations into the gene encoding a target enzyme, in this case PON1. The mutated versions of the gene are then put back into bacteria, which produce the enzymes for testing.

The goal was to end up with enzymes capable of detoxifying G-type nerve agents before those nerve agents could reach their target and cause harm. Those that passed the initial test went on to further rounds of evolution and testing.

After four rounds of evolution, the researchers obtained PON1 variants that worked up to 340 times better than those produced previously. Overall, the researchers reported that the PON1 variants showed 40- to 3,400-fold higher efficiency than the normal enzyme in metabolizing the three most toxic G-type nerve agents.

These new and improved PON1 enzymes have become promising candidates for use as preventive and postexposure treatments in the event of a terrorist attack.

"We hope that our enzymes would be able to act together with currently available drugs to improve survival rates following intoxication," Goldsmith said. More broadly, the findings show the power of laboratory evolution to completely reshape existing enzymes for a variety of uses.
 
Goldsmith et al.: "Evolved stereoselective hydrolases for broad-spectrum G-type nerve agent detoxification."
 
 
PON1 molecular structure. From the lab of Prof. Dan Tawfik
 

 

 
Prof. Dan Tawfik's research is supported by the estate of Mark Scher; Ms. Miel de Botton, UK; and the Sassoon and Marjorie Peress Philanthropic Fund. Prof. Tawfik is the incumbent of the Nella and Leon Benoziyo Professorial Chair.
 
PON1 molecular structure. From the lab of Prof. Dan Tawfik
Chemistry
English

Meetings in the Cell

English

 

Walking across a sparsely occupied plaza, it shouldn’t take long to meet up with a person strolling through from the other side. Now, imagine crossing that same plaza filled with throngs of people. How much longer will one need to reach the other person?

A similar question is often asked by biochemists who study proteins. They can easily observe how long it takes two proteins to interact in a test tube solution. Test tubes are something like open plazas. The insides of cells, however, are extremely crowded spaces: To meet and interact, the proteins must make their way through a teeming mass of other macromolecules in the cell’s cytoplasm. In attempts to partially answer the question, scientists have tried adding other proteins and protein-like substances to their test tubes to simulate the crowd effect.
 
Yet the question remained open. Recently, Prof. Gideon Schreiber, research student Yael Phillip and Dr. Vladimir Kiss of the Biological Chemistry Department decided to resolve the issue by developing a method to directly observe protein interactions in individual living cells. Their results – an experimental first – appeared in the Proceedings of the National Academy of Sciences (PNAS).
 
To measure the interaction rate, the scientists needed a starting point. Creating that moment in time involved manipulating single cells into producing one of the proteins internally. The other protein was carefully injected into the cell with a microscopic needle as the measuring commenced. Both proteins were tagged with fluorescent molecules that produced a glow when an energy transfer took place, showing that binding was occurring between pairs of molecules.
Protein interaction in a cell. Lower left – light microscopy image shows the time from the injection of the second protein. Upper left – donor proteins appear in green. Upper right – as the proteins interact, energy is transferred to the acceptor proteins, causing them to glow red. Lower right – donor and acceptor dynamics combined
      
To their surprise, the scientists found that interaction rates for the proteins they tested were just a bit slower in a cell than they were in test tube solutions. Even when they mutated the proteins to make them faster or slower, the comparative rates did not differ by much.
 
Although they can’t yet be sure, Schreiber and his team think that, while counterintuitive, the crowd scenario could help explain why the protein interaction rates in living cells are faster than might have been expected in the thickly populated cytoplasm. “At first,” he says, “the crowding does slow the proteins down. But as they get closer to one another, the busy throng actually jostles them into meeting. These proteins don’t automatically recognize one another – they can bump into each other many times before an interaction takes place. Bouncing back and forth in the bustling mass of molecules increases the number of chance encounters between the two proteins, and thus the odds of interaction.”
Prof. Gideon Schreiber
 
 
On the one hand, says Schreiber, the new results provide strong evidence that the myriad protein experiments done in test tubes should give a good approximation of the true interaction rate. On the other, the method created in his lab is likely to advance the study of molecular interactions in their natural setting, inside living cells.
 
 
Schreiber: “This is the first time that anyone has managed to observe molecular interaction rates inside a single living cell. With the fluorescent imaging technology, we were literally able to see the interactions as they took place – we could determine not just the rate but the concentration of the different molecules over time as well. The team found that we could even focus on specific areas within the cell body. We are continuing to develop new experiments with the method, and other scientists have already expressed interest in using it to perform various biomolecular studies.”  
 
 
Prof. Gideon Schreiber
Life Sciences
English

Work around the Clock

English
 
There’s a season for everything, King Solomon reportedly said: a time to be born and a time to die, a time for war and a time for peace. Modern science says there’s also the best time to wake up – at 6 am, when metabolism starts running; the best time for love – at 8 am, when sex hormones are about to peak; the best time to see a dentist – at 2 pm, when sensitivity to pain drops; and the worst time to drive – at 2 am, when the body is geared for its deepest sleep.
(l-r) Top: Dr. Adi Neufeld, Tal Shamia and Ziv Zwighaft. Bottom: Drs. Judith Cohen, Gad Asher and Liat Rousso
 
Such peaks and valleys are determined by internal biological “clocks” that operate in approximately 24-hour cycles known as circadian, from Latin, circa diem, meaning “approximately a day.” These clocks regulate the daily fluctuations in heartbeat, blood pressure, kidney function, body temperature, sleeping and waking, sensory perception and the secretion of many hormones. The body’s master circadian clock, residing in the brain, synchronizes a multitude of peripheral clocks present not only in every organ in the body but in every single cell. “Our body is a collection of myriad microscopic clocks that all ‘tick’ in unison,” says Dr. Gad Asher, who recently joined the Weizmann Institute’s Biological Chemistry Department. “Moreover, amazingly enough, these clocks function perfectly well even when the cells are cultured in a laboratory dish.”
 
 
A major aim of Asher’s new lab at the Institute is to find out why we need circadian clocks and how they function. Though science does not yet have an answer to these questions, it’s obvious that the clocks are vital. For one, studies suggest that shift workers tend to have a higher incidence of cancer, diabetes and obesity, as well as signs of accelerated aging, apparently because their circadian clocks are disrupted by work patterns that don’t follow the regular day-and-night cycle. Another indication of the clocks’ importance is their survival throughout millions of years of evolution, from plants and bacteria to humans: Such survival generally means that a mechanism is important enough for nature to keep. Finally, as many as 15 percent of all genes have circadian rhythms. “That’s an incredibly high number – it means that various processes in our bodies run entirely differently at different times of the day,” says Asher.
clock illustration
 
One striking example of such a process was discovered by accident, as often happens in science, in the lab of Prof. Ueli Schibler at the University of Geneva. Several years before Asher joined that lab to conduct his postdoctoral research, Schibler’s team had discovered that a protein called DBP could be purified in unusually high amounts from liver cells. But after the scientists had already published these findings in a prestigious journal, something seemed to go terribly wrong. When they repeated the same experiments, they suddenly couldn’t purify the protein at all. After a brief spell of panic, the quandary was resolved. It turned out that the original experiments had been performed by a student who used to come to the lab at 6 am, as was the custom in his Swiss peasant family. In contrast, the follow-up experiments were conducted by an American student who, needing a rest after late-night partying, used to start work at 2 pm. It so happened that the liver protein under study was regulated by the circadian clock: Its early-morning production was a hundred times higher than in the afternoon.
 
This fascinating discovery gave rise to an entire series of in-depth studies of circadian clocks in Schibler’s Geneva lab. “Geneva is a world leader in all types of clock – not just the Swiss cuckoo clocks, but circadian clocks as well,” says Asher.
 
Among the major questions addressed by Asher’s current studies is how circadian clocks are regulated. It’s known that the master clock in the brain is reset every day by light-dark cycles. As for the clocks in peripheral organs, the major cues for their synchronization are feeding times; it therefore seems that peripheral clocks are extremely sensitive to the metabolic state of cells. While working in Prof. Schibler’s lab, Asher discovered that a protein called SIRT1, which plays a central role in cellular metabolism, also controls the circadian clocks’ function. This discovery, according to the journal Cell, suggests that the SIRT1 might be the “missing link” between metabolism and circadian clocks. In his lab at Weizmann, Asher now intends to expand his studies into the relationship between metabolic factors and circadian mechanisms.

Asher’s ultimate goal is to clarify how circadian clocks work at the molecular and cellular levels, and how the central clock in the brain synchronizes peripheral clocks in other organs. His studies are aimed at answering fundamental biological questions that are related to a wide variety of physiological and pathological conditions – from jetlag and sleep disturbances to cancer, diabetes, obesity and aging.

 

Devoted to science


Born in Ramat Gan, Gad Asher started out by studying mathematics as part of a special program at Tel Aviv University to promote excellence, but then switched to medicine, earning his M.D. degree with distinction in 1998. Already as a medical student, he was fascinated by biological research, spending three summer internships at the Weizmann Institute. While working as a resident internist at the Tel Aviv Sourasky Medical Center, he began doctoral studies in the Weizmann Institute’s Department of Molecular Genetics under the guidance of Prof. Yosef Shaul. Upon earning his Ph.D. degree in 2006, he decided to devote himself entirely to science. After four years of postdoctoral research at the University of Geneva, Switzerland, he joined the Weizmann faculty as a Senior Scientist in May 2011. Outside the lab, he plays classical piano and enjoys bicycle racing and mountain climbing.
 



Dr.  Gad Asher's research is supported by the estate of Dorothy Geller; Ms. Rudolfine Steindling, Austria; and the Willner Family Leadership Institute. 
 
clock illustration
Life Sciences
English

Slow Bonds

English

 

Prof. Irit Sagi, Dr. Dmitry Tworowski, Moran Grossman and Dr. Benjamin Born. Water dymanics
 
 
 
 
 
 
 
 
 

 

 

 
We know that water is essential for life. But the scientists studying life’s processes tend to ignore the water, treating it, at best, as the fluid in which everything floats. That is mainly because water molecules are extremely tiny and fast – even a single protein molecule can be thousands of times larger and slower. The microscopy methods used to observe large biological molecules are usually not able to capture the details of the thousands of water molecules around them.

To find out whether water is more than just the stuff proteins swim in, researchers recently pooled their expertise to see what happens when water molecules interact with an active enzyme. The results, which appeared recently in Nature Structural and Molecular Biology, show that water plays a role in at least one step in the enzymatic process, helping the enzyme to recognize the target site on a second protein.

The particular enzyme chosen belongs to a protein family that has been extensively studied in the lab of Prof. Irit Sagi of the Weizmann Institute’s Biological Regulation Department. This enzyme and its various family members digest other biological molecules; they play a crucial role in everything from cell migration to development and tissue remodeling, and they can also enable cancer cells to migrate in the body.

Sagi, whose innovative, time-lapse, X-ray-based methods have been used to create “movies” of crucial protein activities, teamed up with the group of Prof. Martina Havenith of Ruhr University in Bochum in collaboration with Prof. Gregg Fields of the Torrey Pines Institute for Molecular Studies in Florida. The team combined Sagi’s method with terahertz spectroscopy – based on short pulses of terahertz radiation – to reveal the dynamics of the water molecules together with those of the active enzyme. This novel combination enabled them to record the data at atomic resolution and in real-time.

The enzyme has a metal ion (in this case, zinc) at the core of its active site. This ion, which sits in a cleft in the enzyme structure, mediates the total electric charge in the cleft during the enzyme reaction. Water is naturally drawn to such charged atoms: The oxygen side of the molecule has a slightly negative charge while the two hydrogen atoms, bound at an angle to the oxygen, give the other side a slightly positive charge. (This polarity is what keeps water liquid, as the molecules form brief bonds before sliding past one another.)

The team found that nanoscopic molecular motions of the water in the cleft were very different from those of water molecules surrounding the enzyme or located farther away in the solution. In the presence of the metal ion, the water molecules in the cleft exchanged bonds with one another very slowly. The effect of slowing the bonding was to turn the water viscous – more like thick honey than flowing liquid. In the early stages of the enzyme’s activity, the scientists observed a direct correlation between the transitions from one conformation to another and changes in the motions of the water molecules around the enzyme. As the process continued, the slow-bonding water molecules in the cleft cleared the space for the incoming protein target. The researchers believe that this change in water motion is a general phenomenon that helps enzymes bind, in the right conformation, to the proper site on the target protein substrate.
 
Enzyme dynamics: Blue indicates strongly retarded water molecules; red the freely flowing water near the enzyme surface (gray). Yellow dot is the zinc ion and white indicates substrate molecules that bind to the enzyme
 

 

 
“The marriage of water to protein is really quite a complex process. By combining novel structural-biophysical tools with protein engineering, we managed to advance our understanding of nature’s designs,” says Sagi.

Does water play additional roles in the actions of this enzyme? How does it participate in other biomolecular processes? For Sagi, Havenith and their teams, this study is just the beginning. They believe that understanding the precise role of water in the actions of many different types of biological molecules may be especially useful for designing drugs, including some that they themselves are in the process of developing.
 
Prof. Irit Sagi’s research is supported by the Spencer Charitable Fund; the Leona M. and Harry B. Helmsley Charitable Trust; Cynthia Adelson, Canada; Mireille Steinberg, Canada; the Leonard and Carol Berall Post Doctoral Fellowship; and the Ilse Katz Institute for Material Sciences and Magnetic Resonance Research. Prof. Sagi is the incumbent of the Maurizio Pontecorvo Professorial Chair. 
 
 


 

 
Prof. Irit Sagi, Dr. Dmitry Tworowski, Moran Grossman and Dr. Benjamin Born. Water dymanics
Life Sciences
English

Pages